AXQ Capital’s CorMedix CRMD Stock Holding History

AXQ Capital’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-28,350	Closed	-$192K	–	1057
2026 Q1	$192K	Buy	+28,350	New	+$210K	0.02%	763
2025 Q4	–	Sell	-15,781	Closed	-$184K	–	764
2025 Q3	$184K	Sell	15,781 -3,620	-19%	-$43.8K	0.07%	466
2025 Q2	$239K	Buy	+19,401	New	+$214K	0.08%	426

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AXQ Capital's CRMD Position: Q2 2026 in Review

AXQ Capital sold out of CorMedix (CRMD) in Q2 2026, closing a stake of 28,350 shares — an estimated $192K sold.

AXQ Capital first reported a position in CRMD in Q2 2025 and held it in 3 quarters. The position peaked at $239K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

AXQ Capital reported no remaining CorMedix position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 28,350 CorMedix shares in Q2 2026, an estimated $192K.
AXQ Capital first reported a position in CorMedix in Q2 2025 and held it in 3 quarters.
AXQ Capital's CorMedix position peaked at $239K in Q2 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.